ES2286012T3 - Variantes de alfa-amilasa. - Google Patents
Variantes de alfa-amilasa. Download PDFInfo
- Publication number
- ES2286012T3 ES2286012T3 ES00912415T ES00912415T ES2286012T3 ES 2286012 T3 ES2286012 T3 ES 2286012T3 ES 00912415 T ES00912415 T ES 00912415T ES 00912415 T ES00912415 T ES 00912415T ES 2286012 T3 ES2286012 T3 ES 2286012T3
- Authority
- ES
- Spain
- Prior art keywords
- baselineskip
- alpha
- amylase
- seq
- bacillus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004382 Amylase Substances 0.000 title description 7
- 108090000637 alpha-Amylases Proteins 0.000 claims abstract description 211
- 102000004139 alpha-Amylases Human genes 0.000 claims abstract description 209
- 229940024171 alpha-amylase Drugs 0.000 claims abstract description 172
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 32
- 230000004075 alteration Effects 0.000 claims abstract description 7
- 101710081718 Alpha-amylase I Proteins 0.000 claims abstract 2
- 230000035772 mutation Effects 0.000 claims description 59
- 239000013598 vector Substances 0.000 claims description 26
- 241000194108 Bacillus licheniformis Species 0.000 claims description 25
- 229920002472 Starch Polymers 0.000 claims description 25
- 102200128135 rs61749665 Human genes 0.000 claims description 24
- 235000019698 starch Nutrition 0.000 claims description 24
- 239000008107 starch Substances 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 21
- 241000193744 Bacillus amyloliquefaciens Species 0.000 claims description 15
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims description 14
- 102220123717 rs759057581 Human genes 0.000 claims description 13
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 8
- 244000063299 Bacillus subtilis Species 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 8
- 239000013604 expression vector Substances 0.000 claims description 6
- 102200098673 rs72549321 Human genes 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- 239000000446 fuel Substances 0.000 claims description 4
- 241000193749 Bacillus coagulans Species 0.000 claims description 3
- 241000193422 Bacillus lentus Species 0.000 claims description 3
- 241000193764 Brevibacillus brevis Species 0.000 claims description 3
- 102220626670 Electrogenic sodium bicarbonate cotransporter 1_T49D_mutation Human genes 0.000 claims description 3
- 102220554203 Hemogen_T49V_mutation Human genes 0.000 claims description 3
- 102220644164 Rho guanine nucleotide exchange factor 10-like protein_T49W_mutation Human genes 0.000 claims description 3
- 229940054340 bacillus coagulans Drugs 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 238000003259 recombinant expression Methods 0.000 claims description 3
- 102220008838 rs193922286 Human genes 0.000 claims description 3
- 102220204020 rs200137341 Human genes 0.000 claims description 3
- 102220076573 rs796052533 Human genes 0.000 claims description 3
- 230000032258 transport Effects 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 241000193752 Bacillus circulans Species 0.000 claims description 2
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 241000194109 Paenibacillus lautus Species 0.000 claims description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 2
- 102220158290 rs886062405 Human genes 0.000 claims 1
- 239000013615 primer Substances 0.000 description 82
- 108010075550 termamyl Proteins 0.000 description 79
- 108020004414 DNA Proteins 0.000 description 67
- 238000000034 method Methods 0.000 description 67
- 108091028043 Nucleic acid sequence Proteins 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 41
- 125000000539 amino acid group Chemical group 0.000 description 39
- 238000002703 mutagenesis Methods 0.000 description 36
- 231100000350 mutagenesis Toxicity 0.000 description 36
- 230000000694 effects Effects 0.000 description 32
- 239000013612 plasmid Substances 0.000 description 30
- 108090000623 proteins and genes Proteins 0.000 description 29
- 102000004190 Enzymes Human genes 0.000 description 26
- 108090000790 Enzymes Proteins 0.000 description 26
- 229940088598 enzyme Drugs 0.000 description 26
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 24
- 239000012634 fragment Substances 0.000 description 24
- 239000000758 substrate Substances 0.000 description 21
- 235000001014 amino acid Nutrition 0.000 description 20
- 229940024606 amino acid Drugs 0.000 description 20
- 230000008569 process Effects 0.000 description 17
- 231100000219 mutagenic Toxicity 0.000 description 16
- 230000003505 mutagenic effect Effects 0.000 description 16
- 238000010276 construction Methods 0.000 description 15
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 102100022624 Glucoamylase Human genes 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 238000002708 random mutagenesis Methods 0.000 description 9
- 230000010076 replication Effects 0.000 description 9
- 102220063383 rs786204916 Human genes 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000002538 fungal effect Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- 240000006439 Aspergillus oryzae Species 0.000 description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 235000004279 alanine Nutrition 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 238000003780 insertion Methods 0.000 description 7
- 230000037431 insertion Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 102000013142 Amylases Human genes 0.000 description 6
- 108010065511 Amylases Proteins 0.000 description 6
- 241000228245 Aspergillus niger Species 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 229960005091 chloramphenicol Drugs 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 125000003729 nucleotide group Chemical group 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- 239000004375 Dextrin Substances 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 150000002482 oligosaccharides Polymers 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 235000011148 calcium chloride Nutrition 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019419 proteases Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- -1 amyL Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920000945 Amylopectin Polymers 0.000 description 2
- 101100519158 Arabidopsis thaliana PCR2 gene Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 2
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- 239000006171 Britton–Robinson buffer Substances 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 2
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 2
- 101150102573 PCR1 gene Proteins 0.000 description 2
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 102220493445 Putative uncharacterized protein encoded by MIR7-3HG_A52V_mutation Human genes 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 241000187398 Streptomyces lividans Species 0.000 description 2
- 241001468239 Streptomyces murinus Species 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 108700040099 Xylose isomerases Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 101150049515 bla gene Proteins 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 101150055766 cat gene Proteins 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 102220253319 rs1307934269 Human genes 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 150000004043 trisaccharides Chemical class 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 101710146708 Acid alpha-amylase Proteins 0.000 description 1
- 101710081719 Alpha-amylase B Proteins 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 101100519159 Arabidopsis thaliana PCR3 gene Proteins 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241000351920 Aspergillus nidulans Species 0.000 description 1
- 241000680658 Bacillus deramificans Species 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000122205 Chamaeleonidae Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 101100001650 Geobacillus stearothermophilus amyM gene Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 101001077660 Homo sapiens Serine protease inhibitor Kazal-type 1 Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010028688 Isoamylase Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 102220493444 Putative uncharacterized protein encoded by MIR7-3HG_A52I_mutation Human genes 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235403 Rhizomucor miehei Species 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 102100025144 Serine protease inhibitor Kazal-type 1 Human genes 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101100157012 Thermoanaerobacterium saccharolyticum (strain DSM 8691 / JW/SL-YS485) xynB gene Proteins 0.000 description 1
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 1
- 102220580349 Ubiquitin thioesterase otulin_Y56W_mutation Human genes 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000004507 artificial chromosome Anatomy 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000006085 branching agent Substances 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000000081 effect on glucose Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 108010061330 glucan 1,4-alpha-maltohydrolase Proteins 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 102200071029 rs202003795 Human genes 0.000 description 1
- 102200002990 rs28937320 Human genes 0.000 description 1
- 102200148528 rs587776998 Human genes 0.000 description 1
- 102220140391 rs755697413 Human genes 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 101150110790 xylB gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199900437 | 1999-03-30 | ||
| DK199900437 | 1999-03-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2286012T3 true ES2286012T3 (es) | 2007-12-01 |
Family
ID=8093533
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00912415T Expired - Lifetime ES2286012T3 (es) | 1999-03-30 | 2000-03-28 | Variantes de alfa-amilasa. |
| ES07106717.7T Expired - Lifetime ES2496568T3 (es) | 1999-03-30 | 2000-03-28 | Variantes de alfa-amilasa |
| ES10181113.1T Expired - Lifetime ES2618608T3 (es) | 1999-03-30 | 2000-03-28 | Variantes de alfa-amilasa |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07106717.7T Expired - Lifetime ES2496568T3 (es) | 1999-03-30 | 2000-03-28 | Variantes de alfa-amilasa |
| ES10181113.1T Expired - Lifetime ES2618608T3 (es) | 1999-03-30 | 2000-03-28 | Variantes de alfa-amilasa |
Country Status (15)
| Country | Link |
|---|---|
| EP (3) | EP2290060B1 (https=) |
| JP (1) | JP4668426B2 (https=) |
| KR (1) | KR100808517B1 (https=) |
| CN (1) | CN1252256C (https=) |
| AR (1) | AR023214A1 (https=) |
| AT (1) | ATE360686T1 (https=) |
| AU (1) | AU3419300A (https=) |
| BR (1) | BRPI0009362B8 (https=) |
| CA (1) | CA2365438C (https=) |
| DE (1) | DE60034558T2 (https=) |
| DK (3) | DK2290060T3 (https=) |
| ES (3) | ES2286012T3 (https=) |
| MX (1) | MXPA01009812A (https=) |
| RU (1) | RU2231547C2 (https=) |
| WO (1) | WO2000060059A2 (https=) |
Families Citing this family (201)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2417547A1 (en) | 2000-07-28 | 2003-01-28 | Henkel Kommanditgesellschaft Auf Aktien | Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| EP1370648A2 (en) * | 2000-08-01 | 2003-12-17 | Novozymes A/S | Alpha-amylase mutants with altered properties |
| US20020155574A1 (en) | 2000-08-01 | 2002-10-24 | Novozymes A/S | Alpha-amylase mutants with altered properties |
| EP1326965A2 (en) * | 2000-10-13 | 2003-07-16 | Novozymes A/S | Alpha-amylase variant with altered properties |
| EP1975229A3 (en) * | 2000-10-13 | 2009-03-18 | Novozymes A/S | Alpha-amylase variant with altered properties |
| CA3081363A1 (en) * | 2001-02-21 | 2002-09-06 | Basf Enzymes Llc | Enzymes having alpha amylase activity and methods of use thereof |
| EP2159279A3 (en) | 2001-05-15 | 2010-05-12 | Novozymes A/S | Alpha-amylase variant with altered properties |
| DE10138753B4 (de) * | 2001-08-07 | 2017-07-20 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel mit Hybrid-Alpha-Amylasen |
| US7579177B2 (en) | 2003-05-30 | 2009-08-25 | Novozymes A/S | Alcohol product processes |
| CN104357424A (zh) * | 2004-07-07 | 2015-02-18 | 杜邦营养生物科学有限公司 | 多肽 |
| EP2258837A1 (en) * | 2004-09-10 | 2010-12-08 | Novozymes North America, Inc. | Methods for preventing, removing, reducing, or disrupting biofilm |
| DE102004047776B4 (de) | 2004-10-01 | 2018-05-09 | Basf Se | Gegen Di- und/oder Multimerisierung stabilisierte Alpha-Amylase-Varianten, Verfahren zu deren Herstellung sowie deren Verwendung |
| DE102004047777B4 (de) | 2004-10-01 | 2018-05-09 | Basf Se | Alpha-Amylase-Varianten mit erhöhter Lösungsmittelstabilität, Verfahren zu deren Herstellung sowie deren Verwendung |
| EP2365068B1 (en) | 2004-12-22 | 2017-03-01 | Novozymes A/S | Enzymes for starch processing |
| EP1926753B1 (en) * | 2004-12-22 | 2010-11-24 | Novozymes A/S | Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate-binding module as second amino acid sequence |
| CN101268195A (zh) | 2005-09-20 | 2008-09-17 | 诺维信北美公司 | 产生发酵产物的方法 |
| WO2007076388A2 (en) | 2005-12-22 | 2007-07-05 | Novozymes North America, Inc. | Processes for producing a fermentation product |
| CN101405397A (zh) | 2006-03-22 | 2009-04-08 | 诺维信北美公司 | 发酵方法 |
| RU2426775C2 (ru) * | 2006-04-04 | 2011-08-20 | Новозимс А/С | Способ получения сусла |
| KR20090101193A (ko) * | 2006-12-21 | 2009-09-24 | 다니스코 유에스 인크. | 바실러스 종 １９５ 의 알파-아밀라아제 폴리펩티드에 대한 조성물 및 용도 |
| RU2009139059A (ru) | 2007-03-23 | 2011-04-27 | ДАНИСКО ЮЭс, ИНК., ДЖЕНЕНКОР ДИВИЖН (US) | Улучшенное производство амилазы посредством присоединения к n-концу зрелого белка амилазы |
| ES2748245T3 (es) | 2007-04-24 | 2020-03-16 | Novozymes North America Inc | Detoxificación de materiales que contienen lignocelulosa pretratados |
| WO2009030713A1 (en) | 2007-09-03 | 2009-03-12 | Novozymes A/S | Detoxifying and recycling of washing solution used in pretreatment of lignocellulose-containing materials |
| EP2215201A2 (en) * | 2007-11-05 | 2010-08-11 | Danisco US Inc. | Alpha-amylase variants with altered properties |
| CN102057040A (zh) * | 2008-06-06 | 2011-05-11 | 丹尼斯科美国公司 | 具有改良特性的嗜热脂肪土芽孢杆菌α-淀粉酶(AMYS)变体 |
| US20110097779A1 (en) | 2008-06-23 | 2011-04-28 | Chee-Leong Soong | Processes for Producing Fermentation Products |
| BRPI0919525A2 (pt) | 2008-09-30 | 2015-08-18 | Novozymes North America Inc | Métodos para produzir um produto de fermentação a partir de um material contendo lignocelulose, para intensificar hidrólise enzimática e para reduzir o efeito prejudicial de lignina na hidrólise de um material contendo lignocelulose, e, produto de fermentação |
| CN102292444A (zh) | 2008-11-20 | 2011-12-21 | 诺维信股份有限公司 | 具有淀粉分解增强活性的多肽和编码该多肽的多核苷酸 |
| DK2358873T4 (en) * | 2008-12-15 | 2018-05-28 | Danisco Us Inc | HYBRID ALPHA AMYLASER |
| US20120028299A1 (en) | 2008-12-30 | 2012-02-02 | Novozymes North America, Inc. | Enzymatic Hydrolysis Of Pretreated Lignocellulose-Containing Material With Dissolved Air Flotation Sludge |
| WO2010078392A2 (en) | 2008-12-31 | 2010-07-08 | Novozymes North America, Inc. | Processes of producing fermentation products |
| CN102498401B (zh) | 2009-07-17 | 2015-12-02 | 诺维信公司 | 在纤维素材料水解中分析纤维素衰变的方法 |
| WO2011066560A1 (en) | 2009-11-30 | 2011-06-03 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
| MX2012006096A (es) | 2009-11-30 | 2012-07-03 | Novozymes North America Inc | Polipeptidos que tienen actividad glucoamilasa y polinucleotidos que codifican para los mismos. |
| ES2534067T3 (es) | 2009-12-01 | 2015-04-17 | Novozymes A/S | Polipéptidos que tienen actividad de glucoamilasa y polinucleótidos que codifican los mismos |
| CN102933227A (zh) | 2009-12-22 | 2013-02-13 | 诺维信公司 | 包含增强性多肽和淀粉降解酶的组合物及其用途 |
| US20120270267A1 (en) * | 2010-01-04 | 2012-10-25 | Novozymes A/S | Alpha-Amylases |
| US20130040354A1 (en) | 2010-01-29 | 2013-02-14 | Novozymes A/S | Biogas Production Process With Enzymatic Pre-Treatment |
| WO2011100161A1 (en) | 2010-02-09 | 2011-08-18 | Novozymes North America, Inc. | Addition of alpha - glucosidase and cobalt for producing fermentation products from starch |
| US9896673B2 (en) * | 2010-02-10 | 2018-02-20 | Novozymes A/S | Compositions of high stability alpha amylase variants |
| EP2553111B1 (en) | 2010-03-30 | 2016-05-11 | Novozymes A/S | Methods for enhancing by-products from fermentation processes |
| MX338068B (es) | 2010-04-14 | 2016-04-01 | Novozymes As | Polipeptidos que tienen actividad de glucoamilasa y polinucleotidos que codifican los mismos. |
| US20130157307A1 (en) | 2010-08-02 | 2013-06-20 | Novozymes North America, Inc. | Process of Producing A Fermentation Product |
| CN103298932B (zh) | 2010-11-08 | 2016-08-10 | 诺维信公司 | 具有葡糖淀粉酶活性的多肽和编码该多肽的多核苷酸 |
| EP2637515B1 (en) | 2010-11-08 | 2017-09-06 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
| US9057087B2 (en) | 2010-11-19 | 2015-06-16 | Novozymes North America, Inc. | Processes of producing a fermentation product |
| EP2661499A1 (en) | 2011-01-04 | 2013-11-13 | Novozymes A/S | Process for producing biogas from pectin and lignocellulose containing material |
| US9677094B2 (en) | 2011-02-07 | 2017-06-13 | Novozymes A/S | Process of producing a fermentation product |
| MX2013014236A (es) | 2011-06-28 | 2014-01-23 | Novozymes As | Biogas a partir de bagazo tratado con enzimas. |
| ES2834102T3 (es) | 2011-06-30 | 2021-06-16 | Novozymes As | Variantes de alfa-amilasa |
| BR112014000143B1 (pt) | 2011-07-06 | 2021-04-06 | Novozymes A/S | Variante de alfa-amilase, polinucleotídeo isolado, vetor de expressão, célula hospedeira, métodos de produzir uma variante de alfa-amilase, para produzir um produto de fermentação a partir de um material contendo amido, e, para a produção um derivado de amido enzimaticamente modificado |
| EP2734633B1 (en) | 2011-07-22 | 2019-05-01 | Novozymes North America, Inc. | Processes for pretreating cellulosic material and improving hydrolysis thereof |
| CA2846690A1 (en) | 2011-08-26 | 2013-03-07 | Novozymes A/S | Polypeptides having glucoamylase activity and polynucleotides encoding same |
| EA201490568A1 (ru) | 2011-09-06 | 2014-06-30 | Новозимс А/С | Варианты глюкоамилазы и кодирующие их полинуклеотиды |
| EA201490649A1 (ru) | 2011-10-11 | 2014-07-30 | Новозимс А/С | Варианты глюкоамилазы и кодирующие их полинуклеотиды |
| MX353581B (es) | 2011-10-11 | 2018-01-19 | Novozymes North America Inc | Procesos para producir productos de fermentacion. |
| RU2014121491A (ru) | 2011-10-28 | 2015-12-10 | ДАНИСКО ЮЭс ИНК. | Варианты вариантной альфа-амилазы, образующей мальтогексаозу |
| IN2014CN04905A (https=) | 2011-12-02 | 2015-09-18 | Novozymes As | |
| WO2013083801A2 (en) | 2011-12-09 | 2013-06-13 | Novozymes A/S | Biogas from substrates comprising animal manure and enzymes |
| EP2794899A1 (en) | 2011-12-21 | 2014-10-29 | Novozymes, Inc. | Methods for determining the degradation of a biomass material |
| CN104334738B (zh) | 2012-03-30 | 2019-01-29 | 诺维信北美公司 | 生产发酵产物的方法 |
| US9828595B2 (en) | 2012-08-17 | 2017-11-28 | Novozymes A/S | Thermostable asparaginase variants and polynucleotides encoding same |
| EP2925849A2 (en) * | 2012-11-30 | 2015-10-07 | Novozymes A/S | Polypeptides for cleaning or detergent compositions |
| DK2970931T3 (en) | 2013-03-11 | 2018-01-22 | Danisco Us Inc | COMBINATORY ALPHA AMYLASE VARIATIONS |
| CA2904022C (en) | 2013-04-30 | 2022-04-19 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| WO2014177541A2 (en) | 2013-04-30 | 2014-11-06 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| DK3882346T3 (da) | 2013-05-29 | 2025-12-22 | Danisco Us Inc | Hidtil ukendte metalloproteaser |
| WO2014194032A1 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
| EP3004342B1 (en) | 2013-05-29 | 2023-01-11 | Danisco US Inc. | Novel metalloproteases |
| WO2014194034A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
| AU2014301244B8 (en) | 2013-06-26 | 2018-01-18 | Novonesis Animal Biosolutions Ag | Process for manufacturing a feed composition |
| HUE040545T2 (hu) | 2013-07-17 | 2019-03-28 | Novozymes As | Pullulanáz kimérák és az azokat kódoló polinukleotidok |
| US9951364B2 (en) | 2013-09-11 | 2018-04-24 | Novozymes A/S | Processes for producing fermentation products |
| EP3080263B1 (en) | 2013-12-13 | 2019-07-03 | Danisco US Inc. | Serine proteases of the bacillus gibsonii-clade |
| US20160312204A1 (en) | 2013-12-13 | 2016-10-27 | Danisco Us Inc. | Serine proteases of bacillus species |
| US10005850B2 (en) | 2013-12-16 | 2018-06-26 | E I Du Pont De Nemours And Company | Use of poly alpha-1,3-glucan ethers as viscosity modifiers |
| US9957334B2 (en) | 2013-12-18 | 2018-05-01 | E I Du Pont De Nemours And Company | Cationic poly alpha-1,3-glucan ethers |
| EP3415624B1 (en) | 2014-01-22 | 2021-08-04 | Novozymes A/S | Pullulanase variants and polynucleotides encoding same |
| WO2015123323A1 (en) | 2014-02-14 | 2015-08-20 | E. I. Du Pont De Nemours And Company | Poly-alpha-1,3-1,6-glucans for viscosity modification |
| EP3116914B8 (en) | 2014-03-11 | 2021-04-21 | E. I. du Pont de Nemours and Company | Oxidized poly alpha-1,3-glucan as detergent builder |
| WO2015143144A1 (en) | 2014-03-19 | 2015-09-24 | Novozymes A/S | Method for enhancing activity of an x143 polypeptide |
| MX2016012044A (es) | 2014-03-21 | 2017-06-29 | Danisco Us Inc | Serina proteasas de especies de bacillus. |
| US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| EP3919599A1 (en) | 2014-06-19 | 2021-12-08 | Nutrition & Biosciences USA 4, Inc. | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
| DK3207129T3 (da) | 2014-10-17 | 2020-02-24 | Danisco Us Inc | Serinproteaser af bacillus-arten |
| WO2016062875A2 (en) | 2014-10-23 | 2016-04-28 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| EP3212783B1 (en) | 2014-10-27 | 2024-06-26 | Danisco US Inc. | Serine proteases |
| DK3212662T3 (da) | 2014-10-27 | 2020-07-20 | Danisco Us Inc | Serinproteaser |
| CN107148472A (zh) | 2014-10-27 | 2017-09-08 | 丹尼斯科美国公司 | 芽孢杆菌属物种的丝氨酸蛋白酶 |
| EP3212781B1 (en) | 2014-10-27 | 2019-09-18 | Danisco US Inc. | Serine proteases |
| WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
| CN107109450A (zh) | 2014-12-23 | 2017-08-29 | 纳幕尔杜邦公司 | 酶促产生的纤维素 |
| EP4219704A3 (en) | 2015-05-13 | 2023-08-23 | Danisco US Inc | Aprl-clade protease variants and uses thereof |
| WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
| WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
| EP3307427B1 (en) | 2015-06-09 | 2023-08-16 | Danisco US Inc. | Osmotic burst encapsulates |
| JP7015695B2 (ja) | 2015-06-17 | 2022-02-03 | ダニスコ・ユーエス・インク | バチルス・ギブソニイ（Ｂａｃｉｌｌｕｓ ｇｉｂｓｏｎｉｉ）クレードセリンプロテアーゼ |
| US10676727B2 (en) | 2015-06-18 | 2020-06-09 | Novozymes A/S | Polypeptides having trehalase activity and the use thereof in process of producing fermentation products |
| EP3371308B1 (en) | 2015-11-05 | 2022-05-11 | Danisco US Inc. | Paenibacillus sp. mannanases |
| CN108603183B (zh) | 2015-11-05 | 2023-11-03 | 丹尼斯科美国公司 | 类芽孢杆菌属物种和芽孢杆菌属物种甘露聚糖酶 |
| WO2017083229A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
| WO2017083228A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
| EP3374488B1 (en) | 2015-11-13 | 2020-10-14 | DuPont Industrial Biosciences USA, LLC | Glucan fiber compositions for use in laundry care and fabric care |
| EP3387124B1 (en) | 2015-12-09 | 2021-05-19 | Danisco US Inc. | Alpha-amylase combinatorial variants |
| US20180362946A1 (en) | 2015-12-18 | 2018-12-20 | Danisco Us Inc. | Polypeptides with endoglucanase activity and uses thereof |
| CN108699570A (zh) | 2015-12-22 | 2018-10-23 | 诺维信公司 | 从酒糟水提取油的工艺 |
| CN105802940B (zh) * | 2016-04-18 | 2019-04-16 | 广西大学 | 一种地衣芽胞杆菌高温α-淀粉酶突变体及其应用 |
| BR112018072530A2 (pt) | 2016-05-03 | 2019-03-26 | Danisco Us Inc | variantes de protease e usos das mesmas |
| BR112018072586A2 (pt) | 2016-05-05 | 2019-02-19 | Danisco Us Inc | variantes de protease e usos das mesmas |
| CA3026064A1 (en) | 2016-05-31 | 2017-12-07 | Danisco Us Inc. | Protease variants and uses thereof |
| CA3027745A1 (en) | 2016-06-17 | 2017-12-21 | Danisco Us Inc. | Protease variants and uses thereof |
| WO2018085524A2 (en) | 2016-11-07 | 2018-05-11 | Danisco Us Inc | Laundry detergent composition |
| US10889836B2 (en) | 2016-11-23 | 2021-01-12 | Novozymes A/S | Yeast for ethanol production |
| EP3548615A1 (en) | 2016-11-29 | 2019-10-09 | Novozymes A/S | Alpha-amylase variants and polynucleotides encoding same |
| US11946081B2 (en) | 2016-12-21 | 2024-04-02 | Danisco Us Inc. | Bacillus gibsonii-clade serine proteases |
| EP4520820A3 (en) | 2016-12-21 | 2025-04-16 | Danisco Us Inc | Protease variants and uses thereof |
| EP3585910B1 (en) | 2017-02-24 | 2024-03-20 | Danisco US Inc. | Compositions and methods for increased protein production in bacillus licheniformis |
| EP3583210B1 (en) | 2017-03-15 | 2021-07-07 | Danisco US Inc. | Trypsin-like serine proteases and uses thereof |
| US20200040283A1 (en) | 2017-03-31 | 2020-02-06 | Danisco Us Inc | Delayed release enzyme formulations for bleach-containing detergents |
| DK3601553T3 (da) | 2017-03-31 | 2026-02-16 | Danisco Us Inc | Alfa-amylase-kombinationsvarianter |
| WO2018222990A1 (en) | 2017-06-02 | 2018-12-06 | Novozymes A/S | Improved yeast for ethanol production |
| ES2908190T3 (es) | 2017-06-28 | 2022-04-28 | Novozymes As | Polipéptidos con actividad de trehalasa y polinucleótidos que los codifican |
| CA3067837A1 (en) | 2017-06-30 | 2019-01-03 | Danisco Us Inc | Low-agglomeration, enzyme-containing particles |
| CA3070281A1 (en) | 2017-08-08 | 2019-02-14 | Novozymes A/S | Polypeptides having trehalase activity and the use thereof in process of producing fermentation products |
| EP3668973A2 (en) | 2017-08-18 | 2020-06-24 | Danisco US Inc. | Alpha-amylase variants |
| US11879127B2 (en) | 2017-08-23 | 2024-01-23 | Danisco Us Inc. | Methods and compositions for efficient genetic modifications of Bacillus licheniformis strains |
| WO2019055261A1 (en) | 2017-09-13 | 2019-03-21 | Danisco Us Inc | MODIFIED 5 'NON-TRANSLATED REGION (UTR) SEQUENCES FOR INCREASED PROTEIN PRODUCTION IN BACILLUS |
| US12227784B2 (en) | 2017-09-15 | 2025-02-18 | Novozymes A/S | Enzyme blends and processes for improving the nutritional quality of animal feed |
| BR112020007814A2 (pt) | 2017-10-23 | 2020-10-20 | Novozymes A/S | processos para reduzir e/ou prevenir um aumento nos níveis de ácido lático em um sistema de fermentação de biocombustível e para produção de um produto de fermentação a partir de um material contendo amido, e, uso de um polipeptídeo, ou uma composição enzimática |
| EP3703661A1 (en) | 2017-11-02 | 2020-09-09 | Danisco US Inc. | Freezing point depressed solid matrix compositions for melt granulation of enzymes |
| EP3717643A1 (en) | 2017-11-29 | 2020-10-07 | Danisco US Inc. | Subtilisin variants having improved stability |
| CN111492054A (zh) | 2017-12-08 | 2020-08-04 | 诺维信公司 | α-淀粉酶变体以及对其进行编码的多核苷酸 |
| ES2955269T3 (es) | 2017-12-08 | 2023-11-29 | Novozymes As | Variantes de alfa-amilasa y polinucleótidos que codifican las mismas |
| EP3728543B1 (en) | 2017-12-21 | 2025-10-29 | Danisco US Inc. | Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant |
| JP7280269B2 (ja) | 2018-01-03 | 2023-05-23 | ダニスコ・ユーエス・インク | タンパク質の産生増加のための変異及び遺伝子改変バチルス属（ｂａｃｉｌｌｕｓ）細胞、並びにその方法 |
| CA3089135A1 (en) | 2018-01-29 | 2019-08-01 | Novozymes A/S | Microorganisms with improved nitrogen utilization for ethanol production |
| US20200359656A1 (en) | 2018-02-08 | 2020-11-19 | Danisco Us Inc. | Thermally-resistant wax matrix particles for enzyme encapsulation |
| US11473109B2 (en) | 2018-02-15 | 2022-10-18 | Novozymes A/S | Yeast for ethanol production |
| US10808234B2 (en) | 2018-05-04 | 2020-10-20 | Fornia Biosolutions, Inc. | Variant amylase enzyme compositions and methods |
| CA3098718A1 (en) | 2018-05-31 | 2019-12-05 | Novozymes A/S | Processes for enhancing yeast growth and productivity |
| WO2019245704A1 (en) | 2018-06-19 | 2019-12-26 | Danisco Us Inc | Subtilisin variants |
| EP3799601A1 (en) | 2018-06-19 | 2021-04-07 | Danisco US Inc. | Subtilisin variants |
| BR112021001282A2 (pt) | 2018-07-25 | 2021-04-27 | Novozymes A/S | levedura expressando enzimas para produção de etanol |
| US12584119B2 (en) | 2018-07-31 | 2026-03-24 | Danisco Us Inc | Variant alpha-amylases having amino acid substitutions that lower the PKA of the general acid |
| EP3844255A1 (en) | 2018-08-30 | 2021-07-07 | Danisco US Inc. | Enzyme-containing granules |
| JP2022503923A (ja) | 2018-09-27 | 2022-01-12 | ダニスコ・ユーエス・インク | 医療用器具を洗浄するための組成物 |
| CA3114783A1 (en) | 2018-10-08 | 2020-04-16 | Novozymes A/S | Enzyme-expressing yeast for ethanol production |
| WO2020077331A2 (en) | 2018-10-12 | 2020-04-16 | Danisco Us Inc | Alpha-amylases with mutations that improve stability in the presence of chelants |
| CN109207458B (zh) * | 2018-10-31 | 2021-06-25 | 福州大学 | 耐热型中温α-淀粉酶及其应用 |
| EP3887515A1 (en) | 2018-11-28 | 2021-10-06 | Danisco US Inc. | Subtilisin variants having improved stability |
| WO2020160126A1 (en) | 2019-01-31 | 2020-08-06 | Novozymes A/S | Polypeptides having xylanase activity and use thereof for improving the nutritional quality of animal feed |
| WO2020206058A1 (en) | 2019-04-02 | 2020-10-08 | Novozymes A/S | Process for producing a fermentation product |
| CN114174504B (zh) | 2019-05-24 | 2026-04-17 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
| EP4004029A1 (en) | 2019-07-26 | 2022-06-01 | Novozymes A/S | Microorganisms with improved nitrogen transport for ethanol production |
| BR112022002203A2 (pt) | 2019-08-05 | 2022-09-06 | Novozymes As | Misturas de enzimas e processos para produção de um ingrediente alimentar com alto teor de proteína a partir de um subproduto de vinhaça completa |
| MX2021015818A (es) | 2019-08-06 | 2022-02-03 | Novozymes As | Proteinas de fusion para mejorar la expresion de enzimas. |
| WO2021030267A1 (en) | 2019-08-14 | 2021-02-18 | Danisco Us Inc | Compositions and methods for increased protein production in bacillus licheniformis |
| CA3152952A1 (en) | 2019-09-16 | 2021-03-25 | Novozymes A/S | Polypeptides having beta-glucanase activity and polynucleotides encoding same |
| EP4048683A2 (en) | 2019-10-24 | 2022-08-31 | Danisco US Inc | Variant maltopentaose/maltohexaose-forming alpha-amylases |
| EP4058553A1 (en) | 2019-11-11 | 2022-09-21 | Danisco US Inc. | Compositions and methods for enhanced protein production in bacillus cells |
| AU2020402990A1 (en) | 2019-12-10 | 2022-06-09 | Novozymes A/S | Microorganism for improved pentose fermentation |
| MX2022006438A (es) | 2019-12-16 | 2022-06-22 | Novozymes As | Procesos para obtener productos de fermentacion. |
| CN114945665A (zh) | 2020-01-15 | 2022-08-26 | 丹尼斯科美国公司 | 用于增强地衣芽孢杆菌中蛋白产生的组合物和方法 |
| US20240228996A1 (en) | 2020-02-10 | 2024-07-11 | Novozymes A/S | Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| US20240034960A1 (en) | 2020-08-27 | 2024-02-01 | Danisco Us Inc | Enzymes and enzyme compositions for cleaning |
| WO2022090564A1 (en) | 2020-11-02 | 2022-05-05 | Novozymes A/S | Glucoamylase variants and polynucleotides encoding same |
| EP4284906A1 (en) | 2021-01-29 | 2023-12-06 | Danisco US Inc. | Compositions for cleaning and methods related thereto |
| EP4294823A1 (en) | 2021-02-22 | 2023-12-27 | Danisco US Inc. | Methods and compositions for producing proteins of interest in pigment deficient bacillus cells |
| US20240218300A1 (en) | 2021-03-26 | 2024-07-04 | Novozymes A/S | Detergent composition with reduced polymer content |
| WO2023278297A1 (en) | 2021-06-30 | 2023-01-05 | Danisco Us Inc | Variant lipases and uses thereof |
| US20240352499A1 (en) | 2021-08-20 | 2024-10-24 | Danisco Us Inc. | Polynucleotides encoding novel nucleases, compositions thereof and methods thereof for eliminating dna from protein preparations |
| EP4396320A2 (en) | 2021-09-03 | 2024-07-10 | Danisco US Inc. | Laundry compositions for cleaning |
| EP4402258A2 (en) | 2021-09-13 | 2024-07-24 | Danisco US Inc. | Bioactive-containing granules |
| WO2023114988A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Variant maltopentaose/maltohexaose-forming alpha-amylases |
| EP4448751A2 (en) | 2021-12-16 | 2024-10-23 | Danisco US Inc. | Subtilisin variants and methods of use |
| WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
| EP4448750A2 (en) | 2021-12-16 | 2024-10-23 | Danisco US Inc. | Subtilisin variants and uses thereof |
| WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
| CN119630280A (zh) | 2022-05-14 | 2025-03-14 | 诺维信公司 | 用于预防、处理、抑制和/或消除植物病原性侵染和感染的组合物和方法 |
| CN119487167A (zh) | 2022-06-21 | 2025-02-18 | 丹尼斯科美国公司 | 用于清洁的包含具有嗜热菌蛋白酶活性的多肽的组合物和方法 |
| CN115820606B (zh) * | 2022-07-13 | 2025-02-11 | 青岛蔚蓝生物集团有限公司 | 高比活淀粉酶突变体及其应用 |
| EP4581137A1 (en) | 2022-09-02 | 2025-07-09 | Danisco Us Inc | Mannanase variants and methods of use |
| CN120112635A (zh) | 2022-09-02 | 2025-06-06 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体及其相关方法 |
| EP4581119A1 (en) | 2022-09-02 | 2025-07-09 | Danisco US Inc. | Detergent compositions and methods related thereto |
| CN120303400A (zh) | 2022-11-09 | 2025-07-11 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
| EP4638725A1 (en) | 2022-12-19 | 2025-10-29 | Novozymes A/S | Carbohydrate esterase family 3 (ce3) polypeptides having acetyl xylan esterase activity and polynucleotides encoding same |
| CN120693401A (zh) | 2022-12-19 | 2025-09-23 | 诺维信公司 | 包含阿拉伯呋喃糖苷酶和木聚糖酶的组合物及其用于增加半纤维素纤维溶解的用途 |
| CN120380140A (zh) | 2022-12-19 | 2025-07-25 | 诺维信公司 | 具有阿魏酸酯酶和/或乙酰木聚糖酯酶活性的碳水化合物酯酶家族1（ce1）多肽和编码其的多核苷酸 |
| WO2024137252A1 (en) | 2022-12-19 | 2024-06-27 | Novozymes A/S | Process for reducing syrup viscosity in the backend of a process for producing a fermentation product |
| EP4638768A2 (en) | 2022-12-19 | 2025-10-29 | Novozymes A/S | Processes for producing fermentation products using fiber-degrading enzymes with engineered yeast |
| WO2024163584A1 (en) | 2023-02-01 | 2024-08-08 | Danisco Us Inc. | Subtilisin variants and methods of use |
| EP4677080A1 (en) | 2023-03-06 | 2026-01-14 | Danisco US Inc. | Subtilisin variants and methods of use |
| CN120813242A (zh) | 2023-03-16 | 2025-10-17 | 营养与生物科学美国第四公司 | 用于清洁和臭味控制的短芽孢杆菌发酵物提取物及其用途 |
| AU2024303961A1 (en) | 2023-06-13 | 2025-12-11 | Novozymes A/S | Processes for producing fermentation products using engineered yeast expressing a beta-xylosidase |
| WO2025071996A1 (en) | 2023-09-28 | 2025-04-03 | Danisco Us Inc. | Variant cutinase enzymes with improved solubility and uses thereof |
| WO2025085351A1 (en) | 2023-10-20 | 2025-04-24 | Danisco Us Inc. | Subtilisin variants and methods of use |
| WO2025128568A1 (en) | 2023-12-11 | 2025-06-19 | Novozymes A/S | Composition and use thereof for increasing hemicellulosic fiber solubilization |
| WO2026008449A2 (en) | 2024-07-04 | 2026-01-08 | Novozymes A/S | A process for producing a fermentation product and a concentrated protein co-product |
| WO2026024921A1 (en) | 2024-07-25 | 2026-01-29 | The Procter & Gamble Company | Detergent composition comprising a subtilisin variant and methods of use |
| WO2026050315A1 (en) | 2024-08-29 | 2026-03-05 | Danisco Us Inc. | Subtilisin variants and methods of use |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3912590A (en) | 1973-01-03 | 1975-10-14 | Novo Industri As | Procedure for liquefying starch |
| JPS57174089A (en) | 1981-04-20 | 1982-10-26 | Novo Industri As | Chain dividing enzyme product |
| US4760025A (en) | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
| US5234823A (en) | 1986-06-30 | 1993-08-10 | Novo Industri A/S | Chimeric enzymes |
| DK311186D0 (da) | 1986-06-30 | 1986-06-30 | Novo Industri As | Enzymer |
| ES2052565T3 (es) | 1986-07-09 | 1994-07-16 | Novo Nordisk As | Un procedimiento para licuar una suspension de almidon o granos amilaceos. |
| DE3909096A1 (de) | 1989-03-20 | 1990-09-27 | Garabed Antranikian | Alpha-amylase |
| CA2030554C (en) | 1989-06-29 | 2001-08-28 | Wilhelmus J. Quax | Mutant microbial .alpha.-amylases with increased thermal, acid, and/or alkaline stability |
| CA2082279C (en) | 1990-05-09 | 2007-09-04 | Grethe Rasmussen | Cellulase preparation comprising an endoglucanase enzyme |
| EP0563169B2 (en) | 1990-12-21 | 2006-04-12 | Novozymes A/S | ENZYME MUTANTS HAVING A LOW DEGREE OF VARIATION OF THE MOLECULAR CHARGE OVER A pH RANGE |
| CZ293163B6 (cs) | 1993-02-11 | 2004-02-18 | Genencor International, Inc. | Mutanta alfa-amylázy, její použití, kódová DNA pro tuto mutantu, vektor pro expresi, hostitelské buňky, čisticí prostředek a prostředek pro zkapalnění škrobu |
| CN1189558C (zh) | 1993-10-08 | 2005-02-16 | 诺沃奇梅兹有限公司 | 淀粉酶变体 |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| DK0753057T3 (da) | 1994-03-29 | 2006-01-30 | Novozymes As | Alkalisk Bacillus-amylase |
| DE4422198C2 (de) | 1994-06-24 | 1997-08-28 | Audi Ag | Verfahren zum Steuern der elektrischen Beheizung eines Katalysators |
| AR000862A1 (es) | 1995-02-03 | 1997-08-06 | Novozymes As | Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del |
| DK2199378T3 (da) * | 1995-02-03 | 2012-10-29 | Novozymes As | alfa-amylase mutanter |
| EP0904360B1 (en) * | 1996-04-30 | 2013-07-31 | Novozymes A/S | alpha-AMYLASE MUTANTS |
| AU1461497A (en) * | 1996-12-09 | 1998-07-03 | Genencor International, Inc. | Proteins Having Increased Stability |
| US6080568A (en) * | 1997-08-19 | 2000-06-27 | Genencor International, Inc. | Mutant α-amylase comprising modification at residues corresponding to A210, H405 and/or T412 in Bacillus licheniformis |
-
2000
- 2000-03-28 DK DK10181113.1T patent/DK2290060T3/en active
- 2000-03-28 CN CNB008059497A patent/CN1252256C/zh not_active Expired - Lifetime
- 2000-03-28 WO PCT/DK2000/000148 patent/WO2000060059A2/en not_active Ceased
- 2000-03-28 DK DK00912415T patent/DK1165762T3/da active
- 2000-03-28 CA CA2365438A patent/CA2365438C/en not_active Expired - Lifetime
- 2000-03-28 MX MXPA01009812A patent/MXPA01009812A/es unknown
- 2000-03-28 JP JP2000609551A patent/JP4668426B2/ja not_active Expired - Lifetime
- 2000-03-28 DK DK07106717.7T patent/DK1818396T3/da active
- 2000-03-28 AU AU34193/00A patent/AU3419300A/en not_active Abandoned
- 2000-03-28 ES ES00912415T patent/ES2286012T3/es not_active Expired - Lifetime
- 2000-03-28 BR BRPI0009362A patent/BRPI0009362B8/pt active IP Right Grant
- 2000-03-28 RU RU2001129163/13A patent/RU2231547C2/ru active
- 2000-03-28 ES ES07106717.7T patent/ES2496568T3/es not_active Expired - Lifetime
- 2000-03-28 EP EP10181113.1A patent/EP2290060B1/en not_active Expired - Lifetime
- 2000-03-28 KR KR1020017012076A patent/KR100808517B1/ko not_active Expired - Lifetime
- 2000-03-28 AT AT00912415T patent/ATE360686T1/de active
- 2000-03-28 DE DE60034558T patent/DE60034558T2/de not_active Expired - Lifetime
- 2000-03-28 EP EP00912415A patent/EP1165762B1/en not_active Expired - Lifetime
- 2000-03-28 ES ES10181113.1T patent/ES2618608T3/es not_active Expired - Lifetime
- 2000-03-28 EP EP07106717.7A patent/EP1818396B1/en not_active Expired - Lifetime
- 2000-03-30 AR ARP000101431A patent/AR023214A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK1818396T3 (da) | 2014-08-11 |
| EP2290060A1 (en) | 2011-03-02 |
| EP1165762B1 (en) | 2007-04-25 |
| JP4668426B2 (ja) | 2011-04-13 |
| MXPA01009812A (es) | 2002-06-21 |
| AR023214A1 (es) | 2002-09-04 |
| BR0009362A (pt) | 2001-12-26 |
| WO2000060059A2 (en) | 2000-10-12 |
| KR20010108369A (ko) | 2001-12-07 |
| DK2290060T3 (en) | 2017-03-06 |
| DE60034558D1 (de) | 2007-06-06 |
| BRPI0009362B8 (pt) | 2019-08-20 |
| ES2618608T3 (es) | 2017-06-21 |
| DK1165762T3 (da) | 2007-09-03 |
| BRPI0009362B1 (pt) | 2018-11-21 |
| EP1818396A3 (en) | 2007-12-19 |
| CN1252256C (zh) | 2006-04-19 |
| ATE360686T1 (de) | 2007-05-15 |
| EP1165762A2 (en) | 2002-01-02 |
| KR100808517B1 (ko) | 2008-02-29 |
| CA2365438A1 (en) | 2000-10-12 |
| CA2365438C (en) | 2015-07-14 |
| EP2290060B1 (en) | 2016-12-07 |
| WO2000060059A3 (en) | 2001-05-10 |
| EP1818396B1 (en) | 2014-06-18 |
| CN1346404A (zh) | 2002-04-24 |
| DE60034558T2 (de) | 2007-12-27 |
| RU2231547C2 (ru) | 2004-06-27 |
| ES2496568T3 (es) | 2014-09-19 |
| JP2002540785A (ja) | 2002-12-03 |
| EP1818396A2 (en) | 2007-08-15 |
| AU3419300A (en) | 2000-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2286012T3 (es) | Variantes de alfa-amilasa. | |
| ES2432519T3 (es) | Mutantes de alfa-amilasa | |
| US10113157B2 (en) | Alpha-amylase variants | |
| ES2322825T3 (es) | Mutantes de alfa-amilasa. | |
| ES2259249T3 (es) | Variantes de alfa-amilasa. | |
| JP4855632B2 (ja) | 変更された性質を有するα−アミラーゼ突然変異体 | |
| EP1781790B1 (en) | Alpha-amylase variants with altered properties | |
| AU2005202164B2 (en) | Alpha-amylase variants |